Fresenius Buys NxStage
NxStage shareholders have approved a merger agreement with Fresenius Medical Care, which is expected to take place in 2018. Read the story.
Read the full article » | Posted 11-13-2017
- Outset Gets FDA Green Light Posted 08-11-2022
- Outset Halts Tablo Sales for Home Use Pending FDA Review of New Features Posted 07-13-2022
- Baxter Showcases Kidney Care Products Posted 06-10-2022
- DaVita and Medtronic to Launch New Kidney Tech Company Posted 06-10-2022